Sector comparison

  Becton, Dicki...IDEXX Laborat...Align Technol...West Pharmace...Nasdaq 100
Overview  
ISIN  US0758871091US45168D1046US0162551016US9553061055US6311011026
Market Capitalization
59.63 bill. EUR31.04 bill. EUR11.24 bill. EUR15.29 bill. EUR-
Shares Outstanding
287.14 mill.81.33 mill.73.6 mill.72.3 mill.-
Dividend per Share*
3.80 USD- - 0.82 USD-
Dividend Yield
1.68%--0.36%-
P/E Ratio
38.4338.5629.5234.09-
P/E Ratio (with EPS Diluted)*
41.1438.7537.1048.96-
Free Float
77.40%57.24%71.50%67.50%-
Performance  
Exchange  NYSENASDAQNASDAQNYSEIndices Nasdaq
1 Week
-0.65%-4.85%+1.72%+1.80%+1.41%
1 Month
+0.52%-6.58%-19.62%+7.16%-10.90%
3 Months
+0.15%-2.76%-27.36%-31.16%-10.44%
YTD
-0.39%+0.45%-20.29%-29.75%-6.22%
1 Year
-4.53%-21.61%-47.13%-40.64%+10.65%
3 Years
-11.63%-21.21%-60.94%-43.22%+39.57%
5 Years
-6.73%+92.38%-1.80%+60.81%+163.64%
Fundamentals  2024202420242024-
Accounting Standard  US GAAPUS GAAPUS GAAPUS GAAP-
Revenues (in mill.)
20,178 USD3,897.5040 USD3,999.0120 USD2,893.2000 USD-
Revenues Growth Rate
4.16%6.46%3.54%-1.92%-
EBITDA (in mill.)
- - - - -
Operating Result (in mill.)
2,397 USD1,128.3370 USD607.6280 USD569.9000 USD-
Income Before Taxes (in mill.)
2,005 USD1,109.8310 USD608.9590 USD585.5000 USD-
Net Income (in mill.)
1,705 USD887.8670 USD421.3620 USD492.7000 USD-
Net Income Growth Rate
19.73%5.07%-5.32%-16.97%-
Earnings per Share
5.88 USD10.77 USD5.63 USD6.75 USD- USD
Total Equity (in mill.)
25,890 USD1,595.3130 USD3,851.9850 USD2,682.3000 USD-
Equity Ratio
45.19%48.44%61.98%73.62%-
Return on Equity
6.59%55.65%10.94%18.37%-
Book Value per Share
89.55 USD19.62 USD52.34 USD37.10 USD-
Total Assets (in mill.)
57,286 USD3,293.4430 USD6,214.6000 USD3,643.4000 USD-
Return on Assets
2.98%26.96%6.78%13.52%-
Operating Cash Flow (in mill.)
3,844 USD929.0010 USD738.2310 USD653.4000 USD-

 * Latest financial year